We are attending the American Society of Retina Specialists Annual Scientific Meeting this week. Diabetic Macular Edema (DME) is an eye condition occurring in people with diabetes that causes vision loss. @asrs.retinaspecialists #DMEFacts . . . #DiabeticMacularEdema #DiabeticMacularEdemaFacts #DME #visionloss
BioCryst Pharmaceuticals, Inc.
Biotechnology Research
Durham, NC 41,247 followers
We develop oral small-molecule and protein therapeutics to treat hereditary angioedema (HAE) and other rare diseases.
About us
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema (HAE) and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. We are a commercial-stage biotech company with US headquarters in Durham, North Carolina. Our European headquarters is in Dublin, Ireland, and our Discovery Center of Excellence is rooted in Birmingham, Alabama, with many other regional offices around the world. As world leaders in structure-guided drug design, we draw on the strengths and expertise of all our colleagues—from those of us in the field or behind the scenes in our labs, to others based in home offices and around the globe. To view our LinkedIn community guidelines, please visit https://xmrrwallet.com/cmx.pwww.biocryst.com/social-community-guidelines/
- Website
-
https://xmrrwallet.com/cmx.pwww.biocryst.com
External link for BioCryst Pharmaceuticals, Inc.
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Durham, NC
- Type
- Public Company
- Founded
- 1986
- Specialties
- Drug Discovery, Clinical Development, Rare Diseases, Regulatory Affairs, and Product Commercialization
Locations
-
Primary
Get directions
4505 Emperor Blvd.
Suite 200
Durham, NC 27703, US
-
Get directions
2100 Riverchase Center
Birmingham, Alabama 35244, US
-
Get directions
Dublin, IE
Employees at BioCryst Pharmaceuticals, Inc.
Updates
-
We are attending the ASRS – American Society of Retina Specialists Annual Scientific Meeting this week. Diabetic Macular Edema (DME) is an eye condition occurring in people with diabetes that causes vision loss. #DiabeticMacularEdemaFacts #DMEFacts
-
We recently attended the iCAN (International Children's Advisory Network) 2025 Summit where they collaborated with parents, children, and the healthcare community to improve the health and well-being of all children, especially those with chronic conditions and rare diseases.
-
-
Thank you Hereditary Angioedema Association - HAEA for bringing the #HAE community together at the 2025 National Summit, providing us with the opportunity to share our commitment to patients and learn from attendees. #2025USHAEANationalSummit
-
-
Today we are presenting new findings from patient-focused research at the 2025 US Hereditary Angioedema Association - HAEA National Summit. Jon Stonehouse, President and Chief Executive Officer, shares the importance of listening to the #HAE patient community.
-
-
We are excited to attend the 2025 US Hereditary Angioedema Association - HAEA National Summit in Baltimore this week and looking forward to connecting with the #HAE community! https://xmrrwallet.com/cmx.plnkd.in/e8zkBwn4
-
-
We are excited to announce that Babar Ghias joins BioCryst as our new Chief Financial Officer and Head of Corporate Development. Babar brings extensive deal making and operational experience in addition to his previous roles as a CFO in rare disease companies. https://xmrrwallet.com/cmx.pbit.ly/4l9GNt7
-
-
It was wonderful to connect with the broader hereditary angioedema (#HAE) community and collaborate with our industry colleagues in the allergy and immunology field at European Academy of Allergy and Clinical Immunology - EAACI. #EAACI25
-
-
As we wrap up #PrideMonth, we are reminded that when employees feel empowered to be their authentic selves, innovation and collaboration flourish. We’re proud to foster a culture where individuality is not only accepted but celebrated.
-
-
Today we announced the sale of our European business to Neopharmed Gentili. Read more: https://xmrrwallet.com/cmx.pbit.ly/44xFE8N
-